CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Santen Pharmaceutical Co., Ltd. v. Micro Labs Limited

1:16-cv-00353

Overview

Case Number 1:16-cv-00353
Filing Date 2016-05-13
Status Terminated
Termination Date 2018-11-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Micro Labs USA Inc. Operating Company

Represented By

2 Attorneys Listed

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Micro Labs Limited NPE (University / Research)

Represented By

7 Attorneys Listed

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Michelle A. Herrera

Email: michelle.herrera@pillsburylaw.com

Cedric Tan

Email: cedric.tan@pillsburylaw.com

Alton L. Hare , III

Email: alton.hare@pillsburylaw.com

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Kirsten F. Gallacher

Email: kirsten.gallacher@pillsburylaw.com

David N. Patariu

Email: david.patariu@pillsburylaw.com

Sandoz Inc. Operating Company

Represented By

4 Attorneys Listed

Maureen L. Rurka

Email: MRurka@winston.com

Kathleen B. Barry

UNDELIVERABLE EMAIL 8/16/2021

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Oak Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Asahi Glass Co., Ltd. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Santen Pharmaceutical Co., Ltd. Operating Company

Represented By

6 Attorneys Listed

Takashi Okuda

Email: takashi.okuda@hoganlovells.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Ernest Yakob

Email: ernest.yakob@lw.com

Eric J. Lobenfeld

Email: eric.lobenfeld@hoganlovells.com

Arlene L. Chow

Email: arlene.chow@lw.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇯🇵 Japan 🇺🇸 US
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 1 U.S. Courts: 1
USPTO PTAB Trial 2017-05-12
IPR2017-01434

Micro Labs Limited et al. v. Santen Pharmaceutical Co., Ltd. et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2016-05-13
1:16-cv-00354

Santen Pharmaceutical Co., Ltd. v. Sandoz Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5886035
Difluoroprostaglandin derivatives and their use
Filed: 1997-12-18
Issued: 1999-03-23
Expired (Term Ended) +1826d PTA
Expires: 2022-12-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1826 days) / Cellect Scrutiny — Over 1826 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

17

Dispositive

8

Granted

1

Denied

0

Pending / Review

9

Motions by Category

Procedural / Extension Motion 4 Claim Construction / Markman Filing 4 Motion to Stay Pending IPR / Reexam 8 Motion to Stay 1

Key Dispositive Motions & Rulings

Motion to Stay Pending IPR / Reexam Granted
ORDER - The Defendants' Motion to Stay Pending Inter Partes Review ( 71 ) is GRANTED; Within 30 days of the conclusion of the inter partes review proceeding, th...
Entry #85 • 2018-03-27 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
REQUEST for Oral Argument by Micro Labs Limited, Micro Labs USA Inc. re 71 MOTION to Stay Pending Inter Partes Review. (Kraman, Pilar) (Entered: 01/24/2018)
Entry #79 • 2018-01-24 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
REPLY BRIEF re 71 MOTION to Stay Pending Inter Partes Review filed by Micro Labs Limited, Micro Labs USA Inc.. (Poff, Adam) (Entered: 01/17/2018)
Entry #78 • 2018-01-17 Document →
Motion to Stay Pending IPR / Reexam Pending / Under Review
ANSWERING BRIEF in Opposition re 71 MOTION to Stay Pending Inter Partes Review filed by Asahi Glass Co., Ltd., Oak Pharmaceuticals, Inc., Santen Pharmaceutical ...
Entry #76 • 2018-01-10 Document →
Motion to Stay Pending IPR / Reexam Pending
SO ORDERED - re 75 STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Defendants Micro Labs Limited's and Micro Labs USA Inc.'s Motion to Stay Pending Inte...
Entry #— • 2018-01-02
Motion to Stay Pending IPR / Reexam Pending / Under Review
MOTION to Stay Pending Inter Partes Review - filed by Micro Labs Limited, Micro Labs USA Inc.. (Attachments: # 1 Rule 7.1.1 Certification, # 2 Text of Proposed ...
Entry #71 • 2017-12-20 Document →

Docket Entries

(159 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGMENT filed against Micro Labs Limited, Micro Labs USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1931010.) - filed by Santen Pharmaceutical Co., Ltd., Asahi Glass Co., Ltd., Oak Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Attachment 2 replaced on 5/16/2016) (sec). (Entered: 05/13/2016)

Entry #1 • 2016-05-13
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGMENT filed against Micro Labs Limited, Micro Labs USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1931010.) - filed by Santen Pharmaceutical Co., Ltd., Asahi Glass Co., Ltd., Oak Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Attachment 2 replaced on 5/16/2016) (sec). (Entered: 05/13/2016)

Entry #1 • 2016-05-13
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGMENT filed against Micro Labs Limited, Micro Labs USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1931010.) - filed by Santen Pharmaceutical Co., Ltd., Asahi Glass Co., Ltd., Oak Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Attachment 2 replaced on 5/16/2016) (sec). (Entered: 05/13/2016)

Entry #1 • 2016-05-13
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 05/13/2016)

Entry #2 • 2016-05-13
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/7/2016. Date of Expiration of Patent: 12/18/2022.Thirty Month Stay Deadline: 8/10/2019. (nmb) (Entered: 05/13/2016)

Entry #3 • 2016-05-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc